Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Federico II University

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Federico II University

RECRUITINGNCT06162247

Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)

This protocol proposes to prospectively evaluate current epidemiology, pharmacologic and invasive management and clinical outcomes of patients with acute cardiovascular diseases...

Sponsor: Federico II UniversityEnrolling: 50001 location
Acute Cardiovascular DiseaseAcute Coronary SyndromeAcute Heart Failure+1
RECRUITINGNCT06588244

INOCA-NA a Local Prospective Registry

The present study has the following objectives: 1. To investigate the prevalence of INOCA in patients referring for a clinically indicated coronary angiography (CA) c/o Division...

Sponsor: Federico II UniversityEnrolling: 2501 location
Ischemia, MyocardialNon-Obstructive Coronary AtherosclerosisMicrocirculatory Status+1
RECRUITINGNCT07345585

Probiotics for Autism Spectrum Disorders: a Randomized Controlled Trial (The PASD Study)

Autism spectrum disorders (ASD) are a group of severe neurodevelopmental conditions characterized by impaired communication and social interaction, as well as...

Sponsor: Federico II UniversityEnrolling: 501 location
Autism Spectrum Disorder
RECRUITINGNCT05430828

Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.

Sponsor: Federico II UniversityEnrolling: 500020 locations
Hypercholesterolemia
RECRUITINGNCT07375225

Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy

Evaluation of adherence, persistence and efficacy of treatment with alirocumab 300 mg in a real-life Italian population.

Sponsor: Federico II UniversityEnrolling: 15001 location
Hypercholesterolaemia